Today we are honored to have Dr. Josep Bassaganya-Riera, President and CEO of NImmune Biopharma, to talk about how his company is leveraging computational modeling and bioinformatics to develop new therapeutics.

Disclaimer

The information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may be construed as a recommendation or endorsement of any of the companies discussed. Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.